 |
Amphastar Pharmaceuticals
AMPH
|
237 |
$ 21.87 |
2.15 % |
$ 1.02 B |
USA |
 |
I-Mab
IMAB
|
271 |
- |
- |
$ 866 M |
China |
 |
Midatech Pharma plc
MTP
|
245 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 |
- |
- |
$ 40.3 B |
USA |
 |
Aptorum Group Limited
APM
|
4.89 |
$ 0.94 |
5.23 % |
$ 6.91 M |
China |
 |
ACADIA Pharmaceuticals
ACAD
|
332 |
$ 22.67 |
3.23 % |
$ 3.76 B |
USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
32 |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Esperion Therapeutics
ESPR
|
99.7 |
$ 2.02 |
5.5 % |
$ 420 M |
USA |
 |
Advaxis
ADXS
|
88.1 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
AIkido Pharma
AIKI
|
17.9 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Heron Therapeutics
HRTX
|
842 |
$ 1.2 |
0.42 % |
$ 200 M |
USA |
 |
Институт стволовых клеток человека
ISKJ
|
104 |
- |
- |
- |
Russia |
 |
ImmuCell Corporation
ICCC
|
232 |
$ 8.24 |
-1.38 % |
$ 74.4 M |
USA |
 |
Aeterna Zentaris
AEZS
|
115 |
- |
5.93 % |
$ 314 M |
Canada |
 |
Aptinyx
APTX
|
46.9 |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
AgeX Therapeutics
AGE
|
186 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Aridis Pharmaceuticals
ARDS
|
59 |
- |
17.91 % |
$ 11.1 M |
USA |
 |
Aquestive Therapeutics
AQST
|
223 |
$ 4.17 |
2.21 % |
$ 446 M |
USA |
 |
Arcutis Biotherapeutics
ARQT
|
291 |
$ 23.73 |
2.02 % |
$ 3.02 B |
USA |
 |
Jaguar Health
JAGX
|
964 |
$ 0.35 |
-9.42 % |
$ 816 K |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
61.7 |
- |
- |
$ 7.46 M |
Israel |
 |
Autolus Therapeutics plc
AUTL
|
129 |
$ 1.45 |
0.35 % |
$ 386 M |
Britain |
 |
KalVista Pharmaceuticals
KALV
|
213 |
$ 20.06 |
2.18 % |
$ 1.08 B |
Britain |
 |
AstraZeneca PLC
AZN
|
206 |
- |
- |
$ 96.9 B |
Britain |
 |
BioDelivery Sciences International
BDSI
|
436 |
- |
-4.8 % |
$ 255 M |
USA |
 |
BeiGene, Ltd.
BGNE
|
52.6 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
Ligand Pharmaceuticals Incorporated
LGND
|
77.8 |
$ 233.96 |
1.16 % |
$ 4.28 B |
USA |